Skip to main content
OpenTrials
Completed

NCT Number: NCT01131520

Screening Brief Intervention Referral to Treatment (SBIRT) in New Mexico

The purpose of this study is to compare the effectiveness in reducing drug use and its associated problems of a brief intervention for drug use delivered by a behavioral health counselor as compared to a brief intervention delivered by a computerized intervention.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Drug Abuse Chemically-Induced Disorders HIV Risk Behavior Mental Disorders Substance-Related Disorders

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Friends Research Institute

Baltimore, Maryland, 21201, United States

About this study

Drug use is a significant cause of morbidity and mortality in the United States. Efforts to develop and rigorously evaluate methods to provide Screening, Brief Intervention and Referral to Treatment (SBIRT) for drug users are needed. Computerized screening and brief interventions in particular have the potential to circumvent some of the potential problems of integrating SBIRT delivered by a counselor into busy primary care settings. These interventions may reduce drug use among individuals who are using drugs but are not yet drug dependent.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • 18 years or older
  • Moderate risk category on the ASSIST scores

Exclusion criteria

  • planning to move out of New Mexico in the next year
  • receipt of formal drug abuse treatment or a brief intervention for drug use in the past month.

Treatment and study plan

Computerized brief intervention

Behavioral

This is a brief computerized intervention focused on drug use of patients receiving primary care treatment in an outpatient setting. The intervention is delivered in one session.

Counselor delivered brief intervention

Behavioral

This is a one session brief intervention delivered in a primary care setting that is based on motivational interviewing.

Primary outcomes

  1. Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

    Time frame: 3 months post-baseline

    The ASSIST's Global Continuum of Illicit Drug Risk was used. A higher score is considered more severe risk. The scores range from 0 to 308.

  2. Hair Testing

    Time frame: 3 month post-baseline

    The number of participants testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC)

Secondary outcomes

  1. Human Immunodeficiency Virus (HIV) Drug Use Risk Assessment Battery Subscale

    Time frame: 3 months post-baseline

    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

  2. Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

    Time frame: 6 month post-baseline

    ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.

  3. Alcohol, Smoking & Substance Involvement Screening Test (ASSIST) Score

    Time frame: 12 months post-baseline

    ASSIST's Global Continuum of Illicit Drug Risk Score which ranges from 0 to 308. A higher score is associated with higher risk.

  4. Hair Testing

    Time frame: 6 month post-baseline

    The predicted probabilities for testing positive on Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and tetrahydrocannabinol (THC), calculated from generalized estimating equations.

  5. Hair Testing

    Time frame: 12 month post-baseline

    Predicted Probabilities for testing positive on the Radioimmunoassay (RIA) Hair Testing for opiates, cocaine, amphetamine and THC, calculated from generalized estimating equations.

  6. Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale

    Time frame: 6 month post-baseline

    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

  7. Human Immunodeficiency Virus (HIV) Risk Assessment Battery Subscale Score

    Time frame: 12 month post-baseline

    HIV Drug Use Risk Assessment Battery Subscale Score ranges from 0 to 22. A higher score is considered to be associated with higher risk.

Sponsors and collaborators

Lead sponsor

Friends Research Institute, Inc.

Other

Collaborators

  • National Institute on Drug Abuse (NIDA)

Registry information

Official study title

SBIRT in New Mexico

Important dates

Study start
2010
Primary completion
2012
Study completion
2015
First posted
May 27, 2010
Registry last updated
Dec 12, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.